comparemela.com

Latest Breaking News On - Eyevance pharmaceuticals - Page 7 : comparemela.com

Nicox Raises €10 Million in Private Placement

Press Release Nicox Raises €10 Million in Private PlacementNet proceeds from the private placement to extend the cash runway to mid-May 2024Warrants to be issued in the private placement could provide

Australia
Japan
Valbonne
Provence-alpes-côd-azur
France
United-states
Paris
France-general
United-kingdom
Vietnam
Republic-of
Limie

Nicox Provides Third Quarter 2022 Financial and Business

Press Release Nicox Provides Third Quarter 2022 Financial and Business Highlights Topline results of the NCX 470 Mont Blanc Phase 3 glaucoma trial due in.

New-york
United-states
Valbonne
Provence-alpes-côd-azur
France
Paris
France-general
United-kingdom
Brazil
China
London
City-of

Nicox Announces Last Patients Complete Final Visit in NCX 470 Phase 3 Mont Blanc Glaucoma Trial

Press Release Nicox Announces Last Patients Complete Final Visit in NCX 470 Phase 3 Mont Blanc Glaucoma Trial The last patients completed their final (3-month) visit on September 16691 patients

China
Valbonne
Provence-alpes-côd-azur
France
Paris
France-general
United-kingdom
Chinese
Gavin-spencer
Doug-hubatsch
Kepler-cheuvreux-arsene-guekam
Pharma-bio

Nicox to Participate in Financial and Scientific Events in

Press Release Nicox to Participate in Financial and Scientific Events in Q3 2022August 3, 2022 – release at 7:30 am CET Sophia Antipolis, FranceNicox SA.

New-york
United-states
Milan
Lombardia
Italy
Valbonne
Provence-alpes-côd-azur
France
Paris
France-general
United-kingdom
China

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.